Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Cardiac troponins: from myocardial infarction to chronic disease.

Park KC, Gaze DC, Collinson PO, Marber MS.

Cardiovasc Res. 2017 Dec 1;113(14):1708-1718. doi: 10.1093/cvr/cvx183. Review.

2.

Investigating the Effect of a Single Infusion of Reconstituted High-Density Lipoprotein in Patients with Symptomatic Carotid Plaques.

Nasr H, Torsney E, Poston RN, Hayes L, Gaze DC, Basser R, Thompson MM, Loftus IM, Cockerill GW.

Ann Vasc Surg. 2015 Oct;29(7):1380-91. doi: 10.1016/j.avsg.2015.04.084. Epub 2015 Jun 30.

3.

Obesity: subclinical cardiac damage and heart failure.

Gaze DC.

Ann Clin Biochem. 2015 Mar;52(2):302. doi: 10.1177/0004563215570547. No abstract available.

PMID:
28071087
4.
5.

Analytical evaluation of the automated galectin-3 assay on the Abbott ARCHITECT immunoassay instruments.

Gaze DC, Prante C, Dreier J, Knabbe C, Collet C, Launay JM, Franekova J, Jabor A, Lennartz L, Shih J, del Rey JM, Zaninotto M, Plebani M, Collinson PO.

Clin Chem Lab Med. 2014 Jun;52(6):919-26. doi: 10.1515/cclm-2013-0942.

PMID:
24445238
6.

Clot Disruption: the role of the D-dimer in testing for deep vein thrombosis.

Gaze DC.

Biomark Med. 2013 Jun;7(3):400-1. No abstract available.

PMID:
23878872
7.

A sticky situation: fibrinogen and coronary artery disease.

Gaze DC.

Biomark Med. 2013 Jun;7(3):399-400. No abstract available.

PMID:
23878871
8.

A gripping problem: cardiac biomarkers in patients with intermittent claudication.

Gaze DC.

Biomark Med. 2013 Jun;7(3):399. doi: 10.2217/bmm.13.40. No abstract available.

PMID:
23734802
9.

Randomised Assessment of Treatment using Panel Assay of Cardiac markers--Contemporary Biomarker Evaluation (RATPAC CBE).

Collinson PO, Gaze DC, Thokala P, Goodacre S.

Health Technol Assess. 2013;17(15):v-vi, 1-122. doi: 10.3310/hta17150.

10.

Novel biomarkers of cardiac ischemia: where are we at?

Gaze DC.

Biomark Med. 2012 Oct;6(5):633-5. doi: 10.2217/bmm.12.55. No abstract available.

PMID:
23075241
11.

The perils, pitfalls and opportunities of using high sensitivity cardiac troponin.

Gaze DC.

Curr Med Chem. 2011;18(23):3442-5. Review.

PMID:
21756238
12.

High-sensitive cardiac troponin assays: application for prime-time use.

Gaze DC.

Biomark Med. 2010 Jun;4(3):341-3. doi: 10.2217/bmm.10.18. No abstract available.

PMID:
20550467
13.

Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care.

Hildebrandt P, Collinson PO, Doughty RN, Fuat A, Gaze DC, Gustafsson F, Januzzi J, Rosenberg J, Senior R, Richards M.

Eur Heart J. 2010 Aug;31(15):1881-9. doi: 10.1093/eurheartj/ehq163. Epub 2010 Jun 2. Review.

PMID:
20519241
14.

High-sensitivity cardiac troponin: seeing the wood from the trees.

Gaze DC, Collinson PO.

Clin Chem. 2010 Jul;56(7):1197-8. doi: 10.1373/clinchem.2010.147215. Epub 2010 Apr 22. No abstract available.

15.
16.

Cardiac troponins in patients with renal failure: what are we measuring and when should we measure it?

Collinson PO, Gaze DC.

Ann Clin Biochem. 2009 Jul;46(Pt 4):269-70. doi: 10.1258/acb.2009.009058. Epub 2009 May 19. No abstract available.

PMID:
19454536
17.

The diagnostic and prognostic value of tissue Doppler imaging during dobutamine stress echocardiography in end-stage renal disease.

Sharma R, Mehta RL, Brecker SJ, Gaze DC, Gregson H, Streather CP, Collinson PO, Pellerin D.

Coron Artery Dis. 2009 May;20(3):230-7. doi: 10.1097/MCA.0b013e32832ac5eb.

PMID:
19387250
18.

Cardiac troponin elevations in patients presenting with emergency orthopaedic trauma.

Gaze DC.

Injury. 2009 Mar;40(3):338. doi: 10.1016/j.injury.2008.10.031. Epub 2009 Feb 26. No abstract available.

PMID:
19249044
19.

Cardiac troponin in cerebral injury: understanding your laboratory reports.

Gaze DC.

Biomark Med. 2008 Oct;2(5):433-5. doi: 10.2217/17520363.2.5.433. No abstract available.

PMID:
20477418
20.

Ischaemia-modified albumin: clinical utility and pitfalls in measurement.

Collinson PO, Gaze DC.

J Clin Pathol. 2008 Sep;61(9):1025-8. doi: 10.1136/jcp.2007.053363. No abstract available.

PMID:
18755726
21.

Cardiac biomarkers in chronic renal disease.

Collinson PO, Gaze DC.

Scand J Clin Lab Invest Suppl. 2008;241:104-8. doi: 10.1080/00365510802150265.

PMID:
18569976
22.

Multiple molecular forms of circulating cardiac troponin: analytical and clinical significance.

Gaze DC, Collinson PO.

Ann Clin Biochem. 2008 Jul;45(Pt 4):349-55. doi: 10.1258/acb.2007.007229. Review.

PMID:
18583618
23.

Ischemia-modified albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemic chest pain.

Consuegra-Sanchez L, Bouzas-Mosquera A, Sinha MK, Collinson PO, Gaze DC, Kaski JC.

Heart Vessels. 2008 May;23(3):174-80. doi: 10.1007/s00380-007-1031-8. Epub 2008 May 17.

PMID:
18484160
24.

Cardiac troponin I measurement using the ACS:180 to predict four-year cardiac event rate.

Collinson PO, Gaynor GH, Gaze DC.

Ann Clin Biochem. 2008 Mar;45(Pt 2):184-8. doi: 10.1258/acb.2007.007050.

PMID:
18325183
25.
26.

Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin.

Papageorghiou AT, Prefumo F, Leslie K, Gaze DC, Collinson PO, Thilaganathan B.

Hum Reprod. 2008 Apr;23(4):803-6. doi: 10.1093/humrep/den029. Epub 2008 Feb 16.

PMID:
18281685
27.

The role of existing and novel cardiac biomarkers for cardioprotection.

Gaze DC.

Curr Opin Investig Drugs. 2007 Sep;8(9):711-7. Review.

PMID:
17729182
28.

Biomarkers of cardiovascular damage and dysfunction--an overview.

Collinson PO, Gaze DC.

Heart Lung Circ. 2007;16 Suppl 3:S71-82. Epub 2007 Jul 6. Review.

PMID:
17618829
29.

Biomarkers of cardiovascular damage.

Collinson PO, Gaze DC.

Med Princ Pract. 2007;16(4):247-61. Review.

30.

First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development.

Prefumo F, Gaze DC, Papageorghiou AT, Collinson PO, Thilaganathan B.

Hum Reprod. 2007 Jul;22(7):2029-32. Epub 2007 Apr 16.

PMID:
17437959
31.

Markers of muscle ischemia, necrosis, and inflammation following uterine artery embolization in the treatment of symptomatic uterine fibroids.

Banu NS, Gaze DC, Bruce H, Collinson PO, Belli AM, Manyonda IT.

Am J Obstet Gynecol. 2007 Mar;196(3):213.e1-5.

PMID:
17346524
32.

Evaluation of ischaemia-modified albumin as a marker of myocardial ischaemia in end-stage renal disease.

Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, Collinson PO, Brecker SJ.

Clin Sci (Lond). 2007 Jul;113(1):25-32.

PMID:
17284166
33.

Evidence of cardiomyocyte necrosis in glycogen storage disease type II.

Gaze DC, Lawson GJ, Harris A, Collinson PO.

Ann Clin Biochem. 2007 Jan;44(Pt 1):86-8.

PMID:
17270099
34.

Maternal cardiac function in early pregnancies with high uterine artery resistance.

Prefumo F, Sharma R, Brecker SJ, Gaze DC, Collinson PO, Thilaganathan B.

Ultrasound Obstet Gynecol. 2007 Jan;29(1):58-64.

35.

Effects of balloon occlusion during percutaneous coronary intervention on circulating Ischemia Modified Albumin and transmyocardial lactate extraction.

Sinha MK, Vazquez JM, Calvino R, Gaze DC, Collinson PO, Kaski JC.

Heart. 2006 Dec;92(12):1852-3. No abstract available.

36.

Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood.

Zugck C, Nelles M, Katus HA, Collinson PO, Gaze DC, Dikkeschei B, Gurr E, Hayen W, Haass M, Hechler C, van Hoof V, Guerti K, van Waes C, Printzen G, Klopprogge K, Schulz I, Zerback R.

Clin Chem Lab Med. 2006;44(10):1269-77.

37.

Raised plasma N-terminal pro-B-type natriuretic peptide concentrations predict mortality and cardiac disease in end-stage renal disease.

Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, Collinson PO, Brecker SJ.

Heart. 2006 Oct;92(10):1518-9. No abstract available.

38.

Cardiac troponins as biomarkers of drug- and toxin-induced cardiac toxicity and cardioprotection.

Gaze DC, Collinson PO.

Expert Opin Drug Metab Toxicol. 2005 Dec;1(4):715-25. Review.

PMID:
16863435
39.

Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria.

Collinson PO, Gaze DC, Morris F, Morris B, Price A, Goodacre S.

Ann Clin Biochem. 2006 Jul;43(Pt 4):273-80.

PMID:
16824277
40.

Cardiac troponin for the forensic diagnosis of cardiac contusion.

Gaze DC, Collinson PO, Davies SJ.

Forensic Sci Int. 2007 Jul 4;169(2-3):276. Epub 2006 Jun 13. No abstract available.

PMID:
16774811
41.
42.

Mitral annular calcification predicts mortality and coronary artery disease in end stage renal disease.

Sharma R, Pellerin D, Gaze DC, Mehta RL, Gregson H, Streather CP, Collinson PO, Brecker SJ.

Atherosclerosis. 2007 Apr;191(2):348-54. Epub 2006 May 2.

PMID:
16647710
43.

Diagnostic and prognostic role of cardiac troponin I (cTnI) measured on the DPC Immulite.

Collinson PO, Gaze DC, Stubbs PJ, Swinburn J, Khan M, Senior R, Lahiri A.

Clin Biochem. 2006 Jul;39(7):692-6. Epub 2006 Apr 3.

PMID:
16580659
44.
45.

Mitral peak Doppler E-wave to peak mitral annulus velocity ratio is an accurate estimate of left ventricular filling pressure and predicts mortality in end-stage renal disease.

Sharma R, Pellerin D, Gaze DC, Mehta RL, Gregson H, Streather CP, Collinson PO, Brecker SJ.

J Am Soc Echocardiogr. 2006 Mar;19(3):266-73.

PMID:
16500488
46.

Ischemia-modified albumin predicts mortality in ESRD.

Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, Collinson PO, Brecker SJ.

Am J Kidney Dis. 2006 Mar;47(3):493-502.

PMID:
16490629
47.

Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin.

Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF.

Heart. 2006 Jan;92(1):113-4. No abstract available.

48.

Cardiac troponin determination in amniotic fluid.

Gaze DC, Collinson PO.

Croat Med J. 2005 Dec;46(6):999-1000; discussion 1000-1. No abstract available.

49.

Clinical effect of recalibration of the roche cardiac troponin T assay.

Gaze DC, Collinson PO.

Med Princ Pract. 2006;15(1):29-32.

50.

Dynamic left ventricular obstruction: a potential cause of angina in end stage renal disease.

Sharma R, Pellerin D, Gaze DC, Mehta RL, Gregson H, Streather CP, Collinson PO, Brecker SJ.

Int J Cardiol. 2006 Oct 10;112(3):295-301. Epub 2005 Nov 28.

PMID:
16310267

Supplemental Content

Support Center